74 related articles for article (PubMed ID: 25579939)
1. Influence of excipients on characteristics and release profiles of poly(ε-caprolactone) microspheres containing immunoglobulin G.
Erdemli Ö; Keskin D; Tezcaner A
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():391-9. PubMed ID: 25579939
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and release profiles of MPEG-PCL-MPEG microspheres containing immunoglobulin G.
Erdemli Ö; Usanmaz A; Keskin D; Tezcaner A
Colloids Surf B Biointerfaces; 2014 May; 117():487-96. PubMed ID: 24530344
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes.
Erdemli Ö; Özen S; Keskin D; Usanmaz A; Batu ED; Atilla B; Tezcaner A
J Biomater Appl; 2014 Oct; 29(4):524-42. PubMed ID: 24854983
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
Lalla JK; Sapna K
J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
[TBL] [Abstract][Full Text] [Related]
5. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
6. Effect of the covalent modification of horseradish peroxidase with poly(ethylene glycol) on the activity and stability upon encapsulation in polyester microspheres.
Al-Azzam W; Pastrana EA; King B; Méndez J; Griebenow K
J Pharm Sci; 2005 Aug; 94(8):1808-19. PubMed ID: 15986459
[TBL] [Abstract][Full Text] [Related]
7. Release behaviour of carbamazepine-loaded poly(ε-caprolactone)/poly(ethylene oxide) microspheres.
Pepic D; Nikolic MS; Grujic S; Lausevic M; Djonlagic J
J Microencapsul; 2013; 30(2):151-60. PubMed ID: 22852775
[TBL] [Abstract][Full Text] [Related]
8. Formation mechanism and release behavior of poly(epsilon-caprolactone) microspheres containing disodium norcantharidate.
Wang S; Guo S
Eur J Pharm Biopharm; 2008 Aug; 69(3):1176-81. PubMed ID: 18430549
[TBL] [Abstract][Full Text] [Related]
9. Effects of gamma-irradiation on PLGA microspheres loaded with thienorphine.
Yang Y; Gao Y; Mei X
Pharmazie; 2011 Sep; 66(9):694-7. PubMed ID: 22026126
[TBL] [Abstract][Full Text] [Related]
10. Stability Evaluation of Ivermectin-Loaded Biodegradable Microspheres.
Dorati R; Genta I; Colzani B; Modena T; Bruni G; Tripodo G; Conti B
AAPS PharmSciTech; 2015 Oct; 16(5):1129-39. PubMed ID: 25700978
[TBL] [Abstract][Full Text] [Related]
11. The release of 5-fluorouracil from microspheres of poly(epsilon-caprolactone-co-ethylene oxide).
Martini LG; Collett JH; Attwood D
Drug Dev Ind Pharm; 2000 Jan; 26(1):7-12. PubMed ID: 10677804
[TBL] [Abstract][Full Text] [Related]
12. Effect of excipients on the encapsulation efficiency and release of human growth hormone from dextran microspheres.
Vlugt-Wensink KD; Meijer YJ; van Steenbergen MJ; Verrijk R; Jiskoot W; Crommelin DJ; Hennink WE
Eur J Pharm Biopharm; 2007 Nov; 67(3):589-96. PubMed ID: 17540550
[TBL] [Abstract][Full Text] [Related]
13. Silk coating on poly(ε-caprolactone) microspheres for the delayed release of vancomycin.
Zhou J; Fang T; Wen J; Shao Z; Dong J
J Microencapsul; 2011; 28(2):99-107. PubMed ID: 21265711
[TBL] [Abstract][Full Text] [Related]
14. Controlled released of drug from doubled-walled PVA hydrogel/PCL microspheres prepared by single needle electrospraying method.
Zhou X; Hou C; Chang TL; Zhang Q; Liang JF
Colloids Surf B Biointerfaces; 2020 Mar; 187():110645. PubMed ID: 31759777
[TBL] [Abstract][Full Text] [Related]
15. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of gamma-sterilized vancomycin hydrochloride-loaded poly(ɛ-caprolactone) microspheres for the treatment of biofilm-based medical device-related osteomyelitis.
Sarıgöl E; Bozdağ Pehlivan S; Ekizoğlu M; Sağıroğlu M; Çalış S
Pharm Dev Technol; 2017 Sep; 22(6):706-714. PubMed ID: 26498171
[TBL] [Abstract][Full Text] [Related]
17. Osmotic pressure driven protein release from viscous liquid, hydrophobic polymers based on 5-ethylene ketal ε-caprolactone: potential and mechanism.
Babasola IO; Zhang W; Amsden BG
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):765-72. PubMed ID: 23665446
[TBL] [Abstract][Full Text] [Related]
18. Poly (ε-caprolactone) microspheres for prolonged release of selenium nanoparticles.
Filipović N; Veselinović L; Ražić S; Jeremić S; Filipič M; Žegura B; Tomić S; Čolić M; Stevanović M
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():776-789. PubMed ID: 30606591
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
Abdelwahed W; Degobert G; Fessi H
Int J Pharm; 2006 Feb; 309(1-2):178-88. PubMed ID: 16326053
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agent.
Zhang Y; Zhang Y; Guo S; Huang W
Int J Pharm; 2009 Mar; 369(1-2):19-23. PubMed ID: 19041382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
